Saroja Pharma Industries India Limited SAROJAshare price and chart
Saroja Pharma Industries India closed at ₹36.00 on 19 November 2026, up 4.96% on the day. The 52-week range is ₹28.00 to ₹43.30.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on SAROJA
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Specialty Chemicals · 90 peers · mediansWhat it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 3 years this compounded at -15.0% a year. The last twelve months were down -14.3%. Price only, before dividends.
Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itThe promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash fell by ₹0 Cr, after ₹0 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY25 | FY26 |
|---|---|---|
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 11.4% | 13.0% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.60x | 0.83x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Specialty Chemicals| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND Pidilite Industries Limited | 1.61 L cr | 59.9x | 14.3x | 23.5% | 31.8% | 0.00 | 16.8% | +20.9% | 0.73% |
| SRF SRF Limited | 74,518 cr | 32.6x | 4.9x | 13.8% | 14.2% | 0.34 | 12.5% | +34.7% | 0.40% |
| FLUOROCHEM Gujarat Fluorochemicals Limited | 54,690 cr | 81.0x | 6.5x | 7.5% | 9.8% | 0.26 | 11.4% | +45.5% | 0.06% |
| NAVINFLUOR Navin Fluorine International Limited | 52,334 cr | 57.5x | 11.7x | 20.1% | 21.4% | 0.27 | 22.4% | +57.0% | 0.16% |
| AETHER Aether Industries Limited | 22,517 cr | 90.1x | 8.7x | 9.8% | 11.6% | 0.25 | 19.2% | +26.2% | 0.00% |
| DEEPAKNTR Deepak Nitrite Limited | 21,172 cr | 19.9x | 3.3x | 9.8% | 11.5% | 0.25 | 10.9% | +61.8% | 0.48% |
| FINEORG Fine Organic Industries Limited | 16,731 cr | 34.7x | 5.7x | 16.8% | 22.0% | 0.05 | 18.5% | +22.1% | 0.20% |
| AARTIIND Aarti Industries Limited | 16,565 cr | 27.9x | 2.6x | 7.3% | 7.0% | 0.82 | 5.6% | +74.7% | 0.22% |
| ANURAS Anupam Rasayan India Limited | 15,108 cr | 83.8x | 3.0x | 5.8% | 7.4% | 0.34 | 8.9% | +10.2% | 0.11% |
| ATUL Atul Limited | 14,909 cr | 19.3x | 2.3x | 11.5% | 14.9% | 0.02 | 11.3% | +20.9% | 0.59% |
| PRIVISCL Privi Speciality Chemicals Limited | 13,809 cr | 37.0x | 8.8x | 24.8% | 22.2% | 0.61 | 13.4% | +12.0% | 0.42% |
| SUDEEPPHRM Sudeep Pharma Limited | 13,691 cr | 71.9x | 14.3x | 19.4% | 22.5% | 0.19 | 26.6% | +20.9% | 0.12% |
| BASF BASF India Limited | 12,561 cr | 21.0x | 2.9x | 11.1% | 15.2% | 0.00 | 3.5% | +19.4% | 0.86% |
| VINATIORGA Vinati Organics Limited | 12,162 cr | 29.5x | 3.7x | 14.9% | 19.8% | 0.00 | 16.4% | +23.6% | 0.72% |
| ELANTAS Elantas Beck India Limited | 9,554 cr | 51.1x | - | - | - | - | 18.9% | +22.5% | 0.06% |
| JUBLINGREA Jubilant Ingrevia Limited | 9,138 cr | 25.8x | 2.8x | 9.2% | 11.0% | 0.27 | 7.1% | +24.4% | 0.87% |
| NEOGEN Neogen Chemicals Limited | 8,678 cr | 192.9x | 5.5x | 3.6% | 6.6% | 0.99 | 4.0% | +41.8% | 0.03% |
| ALKYLAMINE Alkyl Amines Chemicals Limited | 8,045 cr | 32.5x | 4.9x | 12.3% | 16.6% | 0.01 | 14.1% | +26.1% | 0.64% |
| GALAXYSURF Galaxy Surfactants Limited | 7,777 cr | 19.1x | 2.6x | 10.5% | 13.4% | 0.08 | 6.5% | +36.5% | 1.82% |
| CLEAN Clean Science and Technology Limited | 7,407 cr | 31.8x | 4.4x | 15.3% | 20.7% | 0.00 | 22.5% | +22.4% | 0.86% |
| BALAMINES Balaji Amines Limited | 6,086 cr | 25.6x | 2.9x | 8.1% | 11.0% | 0.07 | 14.6% | +37.3% | 0.59% |
| ACI Archean Chemical Industries Limited | 5,395 cr | 53.8x | 2.8x | 5.5% | 7.8% | 0.28 | 8.3% | +27.5% | 0.57% |
| FCL Fineotex Chemical Limited | 5,245 cr | 31.5x | 5.4x | 14.9% | 18.3% | 0.01 | 13.2% | +181.5% | 0.11% |
| PRASOLCHEM Prasol Chemicals Limited | 4,597 cr | - | 7.5x | - | - | 0.11 | - | - | 0.00% |
| FOSECOIND Foseco India Limited | 4,490 cr | 38.0x | 4.2x | 10.2% | 14.5% | 0.00 | 14.4% | +67.3% | 0.42% |
| YASHO Yasho Industries Limited | 4,361 cr | 50.4x | 8.5x | 5.8% | 9.1% | 1.20 | 7.8% | +89.7% | 0.01% |
| LXCHEM Laxmi Organic Industries Limited | 4,280 cr | 24.9x | 2.0x | 4.1% | 4.7% | 0.34 | 4.9% | +54.7% | 0.19% |
| EPIGRAL Epigral Limited | 4,077 cr | 14.3x | 1.7x | 16.1% | 15.7% | 0.24 | 10.2% | +27.0% | 0.53% |
| CHEMPLASTS Chemplast Sanmar Limited | 3,953 cr | - | 2.5x | -14.6% | -3.6% | 1.11 | -7.6% | +28.1% | 0.00% |
| TATVA Tatva Chintan Pharma Chem Limited | 3,830 cr | 60.9x | 4.7x | 5.5% | 7.1% | 0.21 | 9.7% | +75.9% | 0.12% |
| VISHNU Vishnu Chemicals Limited | 3,725 cr | 24.4x | 3.3x | 14.2% | 16.3% | 0.62 | 8.8% | +7.1% | 0.05% |
| STYRENIX Styrenix Performance Materials Limited | 3,252 cr | 12.9x | 2.2x | 14.4% | 15.9% | 0.16 | 6.8% | +24.4% | 2.49% |
| JUBLCPL Jubilant Agri and Consumer Products Limited | 2,736 cr | 26.1x | 5.2x | 32.6% | 41.1% | 0.33 | 5.1% | +15.0% | 0.00% |
| DDEVPLSTIK Ddev Plastiks Industries Limited | 2,528 cr | 11.6x | 2.3x | 21.8% | 31.1% | 0.06 | 6.3% | +43.8% | 0.72% |
| ROSSARI Rossari Biotech Limited | 2,371 cr | 15.5x | 1.7x | 11.8% | 14.7% | 0.26 | 5.7% | +19.0% | 0.12% |
| NOCIL NOCIL Limited | 2,318 cr | 29.7x | 1.3x | 3.1% | 4.4% | 0.00 | 5.3% | +33.2% | 1.08% |
| SHK S H Kelkar and Company Limited | 1,758 cr | 18.6x | 1.2x | 5.3% | 7.9% | 0.68 | 3.7% | +14.9% | 0.79% |
| INDOKEM Indokem Limited | 1,753 cr | 785.8x | - | - | - | - | 1.2% | +17.3% | 0.00% |
| NITTAGELA Nitta Gelatin India Limited | 1,584 cr | 15.3x | - | - | - | - | 17.5% | +1.5% | 0.40% |
| SAROJA Saroja Pharma Industries India Limited | 14 cr | 9.2x | 0.8x | - | 13.0% | 0.90 | 3.1% | -52.2% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.1 | +2.1 | -16.3 | +17.9 | -1.5 | +1.5 | -9.1 | +36.5 | -0.4 | -4.9 | -7.2 | · | -10.0% 11m |
| 2025 | -5.8 | -16.8 | -19.7 | +2.4 | +8.4 | -13.5 | -1.2 | +33.7 | -6.0 | -4.1 | -2.7 | -4.8 | -33.3% |
| 2024 | -4.7 | -2.8 | -28.5 | +32.3 | -11.7 | +3.7 | +5.7 | +2.3 | +26.6 | -9.1 | +0.3 | +13.2 | +13.2% |
| 2023 | · | · | · | · | · | · | · | · | · | -6.0 | +2.3 | -13.5 | -16.9% 3m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2025-08-19 | SAMDARIA SOURABH · bulk | SELL | 33,600 | ₹56.15 | ₹0.19 Cr |
| 2025-08-19 | SAMDARIA SOURABH · bulk | BUY | 17,600 | ₹55.83 | ₹0.10 Cr |
| 2025-08-18 | KOKILA SANJAY BHEDA · bulk | SELL | 24,000 | ₹46.80 | ₹0.11 Cr |
| 2025-06-17 | VARDAAN NAGPAL · bulk | SELL | 32,000 | ₹35.90 | ₹0.11 Cr |
| 2025-04-23 | PRANAY DATTATREY RAUT · bulk | SELL | 60,800 | ₹39.09 | ₹0.24 Cr |
| 2024-09-03 | VARDAAN NAGPAL · bulk | BUY | 40,000 | ₹52.14 | ₹0.21 Cr |
| 2024-03-15 | KAMLESH NATWARLAL SHAH · bulk | BUY | 32,000 | ₹40.28 | ₹0.13 Cr |
| 2024-03-14 | KAMLESH NATWARLAL SHAH · bulk | SELL | 33,600 | ₹40.62 | ₹0.14 Cr |
- Board outcomeOutcome of Board Meeting13 Nov 2026
Saroja Pharma Industries India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting30 May 2026
Saroja Pharma Industries India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting13 Nov 2025
Saroja Pharma Industries India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting28 May 2025
Saroja Pharma Industries India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test SAROJA. “Buy SAROJA when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free